跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 111,102 条关于
“E2F-high cancers”
全部
111,102
临床试验
88,593
药物
1,910
机构
565
资讯
20,034
去年
Circle Pharma to Reveal Dual Mechanism of Novel Cyclin A/B RxL Inhibitors at AACR 2025
去年
Circle Pharma's Novel Cyclin Inhibitor Shows Promise Against E2F-Driven Cancers in Nature Study
去年
Dana-Farber Researchers Launch Phase 1 Trial of Novel Cyclin Inhibitor for Small Cell Lung Cancer
去年
FDA Approves Zanidatamab (Ziihera®) for HER2-Positive Biliary Tract Cancers
28天前
Australian researchers uncover molecular switch driving triple-negative breast cancer metastasis, pointing to CDK4/6 inhibitor repurposing
4个月前
Ayvakit (Avapritinib): High Response Rates in Rare Cancers and Mastocytosis, With Critical Safety Monitoring Requirements
去年
Vividion Secures Exclusive Rights to First-in-Class WRN Inhibitor VVD-214 for MSI-High Cancers
8个月前
Vividion's WRN Inhibitor VVD-214 Shows Promise for MSI-High Cancers in Journal of Medicinal Chemistry Publication
5个月前
Adcendo Secures $75 Million Series C to Advance First-in-Class ADC Pipeline for High Unmet Need Cancers
去年
Circle Pharma's CID-078 Receives FDA Orphan Drug Designation for Small Cell Lung Cancer Treatment
第 1 页,共 2004 页
上一页
下一页